<html xmlns:v="urn:schemas-microsoft-com:vml"
      xmlns:o="urn:schemas-microsoft-com:office:office"
      xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>13</o:Revision>
  <o:TotalTime>149</o:TotalTime>
  <o:Created>2005-10-10T13:50:00Z</o:Created>
  <o:LastSaved>2005-10-11T14:01:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>678</o:Words>
  <o:Characters>3866</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>32</o:Lines>
  <o:Paragraphs>7</o:Paragraphs>
  <o:CharactersWithSpaces>4747</o:CharactersWithSpaces>
  <o:Version>9.6926</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	font-family:Arial;
	font-style:italic;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1032"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='font-size:9.0pt;font-family:Arial;
color:black;text-decoration:none;text-underline:none'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:141pt;
 height:45pt'>
 <v:imagedata src="./Page2_files/image001.jpg" o:title="InterPro"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=188 height=60
src="./Page2_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Haemoglobin<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy;font-style:normal'>Haemoglobin and Disease<o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Decreased
levels of haemoglobin, with or without the concomitant decrease in red blood
cells, can cause anaemia.<span style="mso-spacerun: yes">  </span>Iron
deficiency is one cause of anaemia, as it directly affects the ability to
produce haem molecules, but there are several other causes of anaemia.<span
style="mso-spacerun: yes">  </span>There can also be other disease profiles
associated with abnormalities in haemoglobin, known generally as
haemoglobinopathies, as well as abnormalities affecting the production of haem
molecules, known as porphyrias.<span style="mso-spacerun: yes">  </span>A few examples
are described below:</p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy'>Sickle Cell Anaemia<o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=0 cellspacing=0 cellpadding=0 align=left style='border-collapse:
 collapse;mso-table-overlap:never;mso-table-lspace:9.0pt;mso-table-rspace:9.0pt;
 mso-table-anchor-vertical:paragraph;mso-table-anchor-horizontal:column;
 mso-table-left:left;mso-table-top:.05pt;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=128 valign=top style='width:95.8pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;mso-element:frame;
  mso-element-frame-hspace:9.0pt;mso-element-wrap:around;mso-element-anchor-vertical:
  paragraph;mso-element-anchor-horizontal:column;mso-element-top:.05pt;
  mso-height-rule:exactly'><!--[if gte vml 1]><v:shape id="_x0000_i1026"
   type="#_x0000_t75" style='width:84.75pt;height:111pt'>
   <v:imagedata src="./Page2_files/image003.jpg" o:title="Sickle cell"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=113 height=148
  src="./Page2_files/image004.jpg" v:shapes="_x0000_i1026"><![endif]></p>
  </td>
  <td width=10 valign=top style='width:7.2pt;background:white;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='mso-element:frame;mso-element-frame-hspace:9.0pt;
  mso-element-wrap:around;mso-element-anchor-vertical:paragraph;mso-element-anchor-horizontal:
  column;mso-element-top:.05pt;mso-height-rule:exactly'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td width=128 valign=top style='width:95.8pt;background:#CC6600;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center;mso-element:frame;
  mso-element-frame-hspace:9.0pt;mso-element-wrap:around;mso-element-anchor-vertical:
  paragraph;mso-element-anchor-horizontal:column;mso-element-top:.05pt;
  mso-height-rule:exactly'><b><span style='color:white'>A sickle cell next to
  regular red blood cells<o:p></o:p></span></b></p>
  </td>
  <td width=10 valign=top style='width:7.2pt;background:white;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='mso-element:frame;mso-element-frame-hspace:9.0pt;
  mso-element-wrap:around;mso-element-anchor-vertical:paragraph;mso-element-anchor-horizontal:
  column;mso-element-top:.05pt;mso-height-rule:exactly'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
 </tr>
</table>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Sickle Cell
Anaemia affects the shape of red blood cells, changing them from a flattened
disc to a sickle or crescent shape.<span style="mso-spacerun: yes"> 
</span>Whereas normal red blood cells are smooth and move easily through blood
vessels, sickle blood cells are hard, inflexible and tend to clump together,
causing them to get stuck in blood vessels as blood clots, thereby blocking the
flow of blood.<span style="mso-spacerun: yes">  </span>This can cause pain,
blood vessel damage and a low red blood cell count (anaemia) due to the more
fragile nature of sickle blood cells.<span style="mso-spacerun: yes"> 
</span>The abnormal sickle shape is due to the presence of abnormal haemoglobin
(haemoglobin S), which contains abnormal beta polypeptide with a single amino
acid substitution at position 6 along the polypeptide chain (the alpha chain is
normal).<span style="mso-spacerun: yes">  </span>The abnormal <span
style='font-family:Symbol'>b</span> chain reduces the amount of oxygen inside
the red blood cell, altering its shape.</p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Heterozygotes,
where one beta chain gene is affected and the other is normal, usually display
normal red blood cells, and it is only when both beta chain genes are affected
(homozygote) that the sickle cell disease is seen.<span style="mso-spacerun:
yes">  </span>However, heterozygote carriers of the disease are better
protected against malaria than people with two normal beta chain genes.<span
style="mso-spacerun: yes">  </span>This malarial protection has caused the
sickle cell gene to reach high levels in indigenous populations in Africa and
India.</p>

<h2><br clear=all>
<span style='color:navy'>Thalassaemia<o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Thalassaemia
is caused when the production of haemoglobin chains is impaired, the most
common forms affecting the alpha globin chain (alpha Thalassaemia) or the beta globin
chain (beta Thalassaemia).<span style="mso-spacerun: yes">  </span>The chains
themselves can be normal, but the amounts produced are not; sometimes the genes
can even be missing.<span style="mso-spacerun: yes">  </span>There are four
genes needed to make the alpha globin chain, with moderate to severe anaemia
resulting when more than two genes are affected.<span style="mso-spacerun:
yes">  </span>With the beta globin chain there are two genes required, the most
severe form of the disease affecting both genes.<span style="mso-spacerun:
yes">  </span>An equal number of alpha and beta globin proteins are required to
make functional adult haemoglobin, and a deficiency in either chain will cause
an imbalance that damages and destroys red blood cells, thereby producing
anaemia.<span style="mso-spacerun: yes">  </span>The deficiency in globin
chains can cause the an abnormal association of globin chains: in the case of
alpha Thalassaemia, beta globin chains combine to produce abnormal beta tetramers
that cannot bind oxygen, whereas with beta Thalassaemia no such alpha tetramers
exist  instead the alpha globin chains become degraded in the absence of beta
globin chains.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy'>Porphyria<o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Porphyria
disorders affect the production of functional haem molecules in haemoglobin.<span
style="mso-spacerun: yes">  </span>The haem component is composed of a porphyrin
ring complex and iron.<span style="mso-spacerun: yes">  </span>Porphyria
affects the production of a functional porphyrin complex through a genetic
mutation at any one of the many enzymatic steps involved in its production.<span
style="mso-spacerun: yes">  </span>While most haem is in the blood associated
with haemoglobin, haem is also required for in several other tissues, including
the liver.<span style="mso-spacerun: yes">  </span>Porphyrias can affect either
the skin (cutaneous porphyria) or the nervous system (acute porphyria).<span
style="mso-spacerun: yes">  </span>Cutaneous porphyria causes the development
of blisters, itching and swelling upon exposure to light, while acute porphyria
causes pain, numbness, paralysis or mental disorders.<span style="mso-spacerun:
yes">  </span></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Certain
light-sensitive drugs have been developed based on the abnormal porphyrin
structures that result from cutaneous porphyria.<span style="mso-spacerun:
yes">  </span>These drugs have been used to treat cancer: <span
style="mso-spacerun: yes"> </span>cancer cells preferentially absorb these porphyrin-like
structures and help to destroy the cancer cells upon exposure to light
treatment involving lasers.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy;font-style:normal'>Carbon Monoxide Poisoning<o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Carbon
monoxide (CO) binds to haemoglobin with a higher affinity (200x greater) than
oxygen, and at the same binding site.<span style="mso-spacerun: yes"> 
</span>Consequently, carbon monoxide will bind haemoglobin preferentially over
oxygen when both are present in the lungs - even small amounts of carbon
monoxide can dramatically reduce the ability of haemoglobin to transport
oxygen. <span style="mso-spacerun: yes"> </span>Levels as low as 0.02% carbon
monoxide can cause headaches and nausea, while a concentration of 0.1% can lead
to unconsciousness. <span style="mso-spacerun: yes"> </span>This accounts for
the suffocation caused by carbon monoxide fumes, such as from the exhaust of a
car engine.<span style="mso-spacerun: yes">  </span>People who smoke heavily
can block up to 20% of the oxygen binding sites in haemoglobin with carbon
monoxide. <span style="mso-spacerun: yes"> </span>When carbon monoxide binds to
haemoglobin it becomes a very bright cherry red (carboxyhaemoglobin), giving
the person the appearance of a healthy glow.</p>

<p class=MsoBodyText style='text-indent:36.0pt'>By contrast, carbon dioxide
(CO2), which is produced as a waste product after aerobic respiration, binds to
haemoglobin at a different site, therefore does not compete with oxygen for binding
to haemoglobin.</p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1 align=center style='text-align:center'>Next:<span style="mso-spacerun:
yes">  </span><a href="Page3.htm">What InterPro Tells Us</a></h1>

<h1 align=center style='text-align:center'>Previous:<span style="mso-spacerun:
yes">  </span><a href="Page1.htm">Haemoglobin, an Oxygen Carrier</a></h1>

</div>

</body>

</html>
